Ethical sourcing Potential sales opportunity in expanding partnerships with animal-free testing providers and cosmetic/pharmaceutical customers seeking compliant in vitro respiratory models to replace animal testing.

Respiratory models Target opportunities in inhalation toxicity testing, airway disease research, and drug safety assessment using 3D human tissue constructs for asthma, COPD, cystic fibrosis, and related indications.

Swiss biotech Leverage Switzerland’s biotech ecosystem and potential grant programs to collaborate on R&D, access local clinical networks, and pursue EU or global funding through joint ventures.

SME footprint As a small to mid-sized player, pitch flexible collaboration models (co-development, contract research, training, or technology licensing) to fit budget-constrained biotech and pharma customers.

Public interest Capitalize on sustainability and cruelty-free trends by aligning with customers requiring alternative models; emphasize PETA-partnered status and ethical testing narratives to enhance brand appeal.